Literature DB >> 12042316

Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in mice.

Jian-Sheng Gong1, Mariko Kobayashi, Hideki Hayashi, Kun Zou, Naoya Sawamura, Shinobu C Fujita, Katsuhiko Yanagisawa, Makoto Michikawa.   

Abstract

We have reported previously (Michikawa, M., Fan, Q.-W., Isobe, I., and Yanagisawa, K. (2000) J. Neurochem. 74, 1008-1016) that exogenously added recombinant human apolipoprotein E (apoE) promotes cholesterol release in an isoform-dependent manner. However, the molecular mechanism underlying this isoform-dependent promotion of cholesterol release remains undetermined. In this study, we demonstrate that the cholesterol release is mediated by endogenously synthesized and secreted apoE isoforms and clarify the mechanism underlying this apoE isoform-dependent cholesterol release using cultured astrocytes prepared from human apoE3 and apoE4 knock-in mice. Cholesterol and phospholipids were released into the culture media, resulting in the generation of two types of high density lipoprotein (HDL)-like particles; one was associated with apoE and the other with apoJ. The amount of cholesterol released into the culture media from the apoE3-expressing astrocytes was approximately 2.5-fold greater than that from apoE4-expressing astrocytes. In contrast, the amount of apoE3 released in association with the HDL-like particles was similar to that of apoE4, and the sizes of the HDL-like particles released from apoE3- and apoE4-expressing astrocytes were similar. The molar ratios of cholesterol to apoE in the HDL fraction of the culture media of apoE3- and apoE4-expressing astrocytes were 250 +/- 6.0 and 119 +/- 5.1, respectively. These data indicate that apoE3 has an ability to generate similarly sized lipid particles with less number of apoE molecules than apoE4, suggesting that apoE3-expressing astrocytes can supply more cholesterol to neurons than apoE4-expressing astrocytes. These findings provide a new insight into the issue concerning the putative alteration of apoE-related cholesterol metabolism in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12042316     DOI: 10.1074/jbc.M203934200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  74 in total

1.  Protection of neurons from apoptosis by apolipoprotein E-containing lipoproteins does not require lipoprotein uptake and involves activation of phospholipase Cgamma1 and inhibition of calcineurin.

Authors:  Hideki Hayashi; Robert B Campenot; Dennis E Vance; Jean E Vance
Journal:  J Biol Chem       Date:  2009-08-28       Impact factor: 5.157

Review 2.  Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets.

Authors:  Lijun Dai; Li Zou; Lanxia Meng; Guifen Qiang; Mingmin Yan; Zhentao Zhang
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

3.  Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer's Disease Models.

Authors:  C Y Daniel Lee; Anthony Daggett; Xiaofeng Gu; Lu-Lin Jiang; Peter Langfelder; Xiaoguang Li; Nan Wang; Yingjun Zhao; Chang Sin Park; Yonatan Cooper; Isabella Ferando; Istvan Mody; Giovanni Coppola; Huaxi Xu; X William Yang
Journal:  Neuron       Date:  2018-03-07       Impact factor: 17.173

4.  ApoE4 Accelerates Early Seeding of Amyloid Pathology.

Authors:  Chia-Chen Liu; Na Zhao; Yuan Fu; Na Wang; Cynthia Linares; Chih-Wei Tsai; Guojun Bu
Journal:  Neuron       Date:  2017-12-06       Impact factor: 17.173

Review 5.  Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis.

Authors:  W Gibson Wood; Ling Li; Walter E Müller; Gunter P Eckert
Journal:  J Neurochem       Date:  2014-01-02       Impact factor: 5.372

Review 6.  Alzheimer's disease as homeostatic responses to age-related myelin breakdown.

Authors:  George Bartzokis
Journal:  Neurobiol Aging       Date:  2009-09-22       Impact factor: 4.673

7.  APOE4-specific changes in Aβ accumulation in a new transgenic mouse model of Alzheimer disease.

Authors:  Katherine L Youmans; Leon M Tai; Evelyn Nwabuisi-Heath; Lisa Jungbauer; Takahisa Kanekiyo; Ming Gan; Jungsu Kim; William A Eimer; Steve Estus; G William Rebeck; Edwin J Weeber; Guojun Bu; Chunjiang Yu; Mary Jo Ladu
Journal:  J Biol Chem       Date:  2012-10-11       Impact factor: 5.157

8.  Systemic treatment with liver X receptor agonists raises apolipoprotein E, cholesterol, and amyloid-β peptides in the cerebral spinal fluid of rats.

Authors:  Sokreine Suon; Jie Zhao; Stephanie A Villarreal; Nikesh Anumula; Mali Liu; Linda M Carangia; John J Renger; Celina V Zerbinatti
Journal:  Mol Neurodegener       Date:  2010-10-29       Impact factor: 14.195

9.  Apolipoprotein E4 (1-272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells.

Authors:  Toshiyuki Nakamura; Atsushi Watanabe; Takahiro Fujino; Takashi Hosono; Makoto Michikawa
Journal:  Mol Neurodegener       Date:  2009-08-20       Impact factor: 14.195

10.  Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures.

Authors:  Robert P Lisak; Joyce A Benjamins; Beverly Bealmear; Liljana Nedelkoska; Diane Studzinski; Ernest Retland; Bin Yao; Susan Land
Journal:  J Neuroinflammation       Date:  2009-01-21       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.